🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

4 recruiting trials

for Advanced Thyroid Gland Medullary Carcinoma

Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors NCT07006727Phase 18 sites📍 Iowa City📍 Boston📍 Royal Oak Novartis Pharmaceuticals · Tests: 225Ac-ETN029, 111In-ETN029 Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001) NCT06141369NA1 site📍 Shanghai Shanghai Jiao Tong University School of Medicine · Tests: individualized mRNA neoantigen vaccine (mRNA-0523-L001) Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management NCT04216732n/a2 sites📍 San Francisco📍 Houston M.D. Anderson Cancer Center · Tests: Blood Pressure Measurement, Questionnaire Administration Study of Anlotinib in Patients With Advanced Medullary Thyroid Carcinoma NCT05830500Phase 419 sites📍 Hefei📍 Beijing📍 Lanzhou Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Tests: Anlotinib Hydrochloride Capsule
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy